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EssentialsThe Hemophilia Joint Health Score (HJHS) is an ordinal validated joint outcome assessment tool.A system using a discrete choice experiment may provide improvements to remove the current limitations of the HJHS score.An integrated approach may improve the HJHS for assessing joint health in clinical and research settings.

1. BACKGROUND {#rth212212-sec-0006}
=============

Hemophilia is a hereditary bleeding disorder, in which recurrent hemarthrosis may lead to rapidly progressive arthropathy.[1](#rth212212-bib-0001){ref-type="ref"}, [2](#rth212212-bib-0002){ref-type="ref"} This may result in lasting functional impairments and participation restriction, as well as pain and deformity.[3](#rth212212-bib-0003){ref-type="ref"}, [4](#rth212212-bib-0004){ref-type="ref"} People with hemophilia may have a reduced quality of life as a result of the physical and psychosocial impact of the disease.[5](#rth212212-bib-0005){ref-type="ref"}

Musculoskeletal outcomes of patients with hemophilia are of great clinical importance.

According to the International Classification of Functioning, Disability and Health, "structure and function" is a major component of an individual\'s outcome in health and disability. Surveillance of musculoskeletal changes is recognized to be essential for timely patient evaluation and subsequent optimization of management.[6](#rth212212-bib-0006){ref-type="ref"}, [7](#rth212212-bib-0007){ref-type="ref"}, [8](#rth212212-bib-0008){ref-type="ref"}

The early initiation of prophylaxis has resulted in the need for a more sensitive assessment tool to identify the subtle joint changes that may lead to arthropathy.[9](#rth212212-bib-0009){ref-type="ref"}, [10](#rth212212-bib-0010){ref-type="ref"} Therefore, a disease‐specific tool focused on commonly affected joints would be more optimal than a generic musculoskeletal assessment tool.

There is currently no gold standard for the (latent) construct of "joint health." The Hemophilia Joint Health Score (HJHS) was developed to assess joint health in people with hemophilia. Through several assessments of joint structure and function---collectively referred to as items---the HJHS produces a measure of joint health. The 9 items assessed to evaluate the status of a joint include swelling, duration of swelling, muscle atrophy, crepitus of motion, range of motion (extension and flexion loss), joint pain, strength, and gait. The summation of the 9 HJHS items in 6 index joints provides users with a relative indicator of joint health, with a lower HJHS representing superior joint health. HJHS scores may assist in the development of individualized musculoskeletal treatment plans or programs. The HJHS is an internationally validated physical examination assessment tool with excellent interobserver and test‐retest reliability.[9](#rth212212-bib-0009){ref-type="ref"}, [10](#rth212212-bib-0010){ref-type="ref"} In addition, the HJHS is frequently used in clinical studies and is thought to be optimal for assessing mild/moderate arthropathy in children and young adults.[7](#rth212212-bib-0007){ref-type="ref"}

The HJHS, as currently scored, provides its users with ordinal data that are, perhaps incorrectly, treated as though they are numerical. For example, single‐ordered category increase, or decrease in 2 HJHS item scores, will score identically with the current system but may not capture differences in the value of true joint health. Consequently, the clinical and research utility of the HJHS may be limited due to its ordinal structure.

Conjoint analysis can be used to develop a weighting scheme for measures such as the HJHS, addressing the limitations associated with simply summing individual ordinal attribute levels.[11](#rth212212-bib-0011){ref-type="ref"} Discrete choice experiments are conjoint analyses; they are survey‐based techniques that enable respondents to make repeated judgments on pairwise comparisons of attributes. The relative importance, or weight, placed on each attribute can then be estimated.[11](#rth212212-bib-0011){ref-type="ref"} Applied to the HJHS, this means the relative importance, or weight, respondents place on each item (and each level within each item) can be determined. This preference weighting can then be used to develop a scoring system that produces continuous scoring (weighted score) that gives more weight to the items considered to be of more relative importance for optimal joint health.

The purpose of this initiative is to use an adaptive, partial‐profile, discrete choice experiment to lay the groundwork toward the development of an updated scoring system for the HJHS. Our goal is to transform the ordinal data created by the HJHS to continuous weighted scores determined by the importance respondents place on each item and level, addressing potential limitations of its current ordinal structure.

2. METHODS {#rth212212-sec-0007}
==========

A conjoint analysis to determine the relative importance respondents place on each HJHS item was used. Our survey provided respondents with discrete choice tasks of ranking alternatives, which were then analyzed to provide the preference weight, or relative importance, individuals place on different criteria.

The survey was developed using 1000Minds decision‐making software ([www.1000minds.com](http://www.1000minds.com)). The specific method used by 1000Minds is known as the Potentially All Pairwise Rankings of all Possible Alternatives (PAPRIKA) method.[12](#rth212212-bib-0012){ref-type="ref"} The PAPRIKA method involves a simple ranking measurement of decision makers' preferences rather than a scaling or ratio measurement. The process minimizes the number of pairwise comparisons respondents need to make by implicitly ranking items against each other using the data obtained from explicit pairwise comparisons. Preference values (weights) are generated for each individual participant using hypothetical real‐world scenarios in contrast to other methods that solely produce aggregate data, which is a major advantage of the PAPRIKA method.[12](#rth212212-bib-0012){ref-type="ref"} As such, our study was an adaptive, partial‐profile, discrete‐choice experiment.

The survey was distributed to an anonymous, random sample (random.org) of members of the Canadian Physiotherapists in Haemophilia Care, the World Federation of Haemophilia Musculoskeletal (WFH MSK) Committee, and the European Association for Haemophilia and Allied Disorders Physiotherapists Committee. These organizations were selected due to the members' extensive experience in the physical examination of joints and bleeding disorders. The respondents were predominantly pediatric and adult physiotherapists, with additional musculoskeletal experts from the WFH MSK committee. Due to the anonymity of the sample, no demographic information is available to report. All potential respondents were initially contacted via email, with subsequent reminders by email correspondence and a direct phone call.

The survey asked respondents to make repeated judgments between 2 hypothetical scenarios they believed represented a "healthier joint." Each scenario consisted of a hypothetical joint scored by 2 HJHS items, as shown in Figure [1](#rth212212-fig-0001){ref-type="fig"}. Through repeated direct pairwise comparisons of 2 scenarios, the preference weight for each item and each level was calculated by regression analysis.[12](#rth212212-bib-0012){ref-type="ref"} The model contains 9 criteria with between 2 and 5 levels. This estimates an average total of 86 400 hypothetical individual simulations, resulting in approximately 93 decisions to be completed by each participant.

![Example of a decision scenario used in the 1000Minds Survey](RTH2-3-405-g001){#rth212212-fig-0001}

The mean, median, and standard deviation of the relative importance of each item was reported as a percentage; the sum of each item\'s relative importance (weight) is therefore 100%. As opposed to the original HJHS, higher scores in the weighted system indicate healthier joints.

The 1000Minds program performed random consistency checks whereby the survey participants were asked to explicitly rank a specific pairwise comparison they previously completed. Four consistency checks were performed for each respondent throughout the survey to assess responder reliability. Respondents with ≥2 valid consistency checks were included in an additional subgroup analysis.

To compare the relative efficiency of the original HJHS to the weighted HJHS, we applied the new weighted scoring system to the HJHS total scores from published data included in a study by Carneiro et al,[13](#rth212212-bib-0013){ref-type="ref"} comparing patients with hemophilia from both resource‐constrained and ‐unconstrained countries. Independent samples *t‐*tests were completed using both the original and weighted HJHS total scores.

3. RESULTS AND DISCUSSION {#rth212212-sec-0008}
=========================

A total of 64 individuals were contacted to participate in our survey with 41 (64%) participants completing the entire survey. The remaining 19 participants completed an average of 5.8% of the required decisions but declined to participate further. Consistency check results are found in Table [1](#rth212212-tbl-0001){ref-type="table"}. Subgroup analysis removed 3 respondents who showed inconsistency. This did not affect the overall results, leading to greater confidence in our total sample.

###### 

Summary of consistency checks performed in the 41 survey participants

  Number of identical answers per repeated question (maximum = 4)   Number of participants (total = 41)
  ----------------------------------------------------------------- -------------------------------------
  1                                                                 3
  2                                                                 21
  3                                                                 11
  4                                                                 6
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The order of the single levels within each item of the HJHS were predetermined in accordance with the HJHS scoring system; the item level representing a healthy joint was given a score of 100, and the worst possible level was given a score of 0. Regression analysis was used to provide the relative preference values for the 9 items of the HJHS as reported in Table [2](#rth212212-tbl-0002){ref-type="table"}. Normalized HJHS item weights sum to 1.0, and the mean scores for each single item level within each HJHS item are reported in Table [3](#rth212212-tbl-0003){ref-type="table"}. The HJHS item with the highest weight was extension loss (normal--contralateral side) (0.139), followed by swelling (0.121). The HJHS item with the lowest weight was duration of swelling (0.057), followed by muscle atrophy (0.08). The range in weights for different HJHS items demonstrate the large variability in the perceived impact these items have on determining joint health. This further strengthens the need for a more descriptive tool that accounts for the perceived impact these clinical indicators have on joint health.

###### 

Relative preference value for item level scores within each HJHS item reported as percent mean, median, and standard deviation (SD) of total responses generated by the regression model

  HJHS item                                                                             Median (%)   Mean (%)   SD (%)
  ------------------------------------------------------------------------------------- ------------ ---------- --------
  Swelling                                                                                                      
   Severe---very swollen, no bony landmarks are visible                                 0            0          0
   Moderate---swollen, bony landmarks obscured to some degree                           2.7          4.5        3.4
   Mild---swelling looks slightly "puffy"; all bony landmarks are visible               6.4          7.9        5.0
   No swelling                                                                          11.2         12.1       6.1
  Duration of swelling                                                                                          
   ≥6 months                                                                            0            0          0
   No swelling or \<6 months                                                            4.2          5.7        4.7
  Muscle atrophy                                                                                                
   Severe---flattening of muscle belly is noted                                         0            0          0
   Mild---mild flattening of muscle belly is noted                                      3.6          4.8        3.3
   None                                                                                 7.7          8.0        4.2
  Crepitus of motion                                                                                            
   Severe---audible and/or palpable grinding and crunching during joint motion          0            0          0
   Mild---slightly audible and/or palpable grinding and crunching during joint motion   4.6          6.6        5.4
   None                                                                                 10.0         10.9       6.7
  Strength                                                                                                      
   Trace or no muscle contraction                                                       0            0          0
   Able to partially complete range of motion against gravity                           3.5          4.7        3.5
   Holds test position with minimal resistance                                          6.8          7.8        4.9
   Holds test position against gravity with moderate resistance                         9.7          10.3       5.8
   Holds test position against gravity with maximum resistance                          11.6         13.0       7.1
  Joint pain                                                                                                    
   Pain through active range                                                            0            0          0
   No pain through active range; pain only on gentle overpressure or palpation          6.8          7.6        3.8
   No pain through active range of motion                                               10.2         11.0       4.5
  Global gait (walking, stairs, running, hopping on 1 leg)                                                      
   No skills are within normal limits                                                   0            0          0
   3 skills are not within normal limits                                                3.1          3.7        3.5
   2 skills are not within normal limits                                                6.5          7.0        4.6
   1 skill is not within normal limits                                                  9.2          10.1       5.8
   All skills are within normal limits                                                  11.8         13.8       7.5
  Flexion loss (normal--contralateral side)                                                                     
   Loss of \>20°                                                                        0            0          0
   Loss of 11°‐20°                                                                      3.3          4.0        2.9
   Loss of 5°‐10°                                                                       7.4          8.2        5.0
   Loss of \<5°                                                                         10.9         11.5       6.0
  Extension loss (normal--contralateral side)                                                                   
   Loss of \>20°                                                                        0            0          0
   Loss of 11°‐20°                                                                      4.5          5.3        4.3
   Loss of 5°‐10°                                                                       8.7          10.0       6.4
   Loss of \<5°                                                                         11.4         13.9       7.6

Values indicate how favorable a level was relative to other levels within an item; a higher score indicates it is more favorable when identifying a healthy joint (N = 41).
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###### 

Normalized HJHS item weights and item level scores (means)

  HJHS item                                                                            Item weight (sum to 1)   Item levels                                                                   Item‐level score (0‐100)
  ------------------------------------------------------------------------------------ ------------------------ ----------------------------------------------------------------------------- --------------------------
  Swelling                                                                             0.121                    Severe---very swollen, no bony landmarks are visible                          0
  Moderate---swollen, bony landmarks obscured to some degree                           36.8                                                                                                   
  Mild---swelling looks slightly "puffy"; all bony landmarks are visible               65                                                                                                     
  No swelling                                                                          100                                                                                                    
  Duration of swelling                                                                 0.057                    ≥6 months                                                                     0
  No swelling or \<6 months                                                            100                                                                                                    
  Muscle atrophy                                                                       0.08                     Severe---flattening of muscle belly is noted                                  0
  Mild---mild flattening of muscle belly is noted                                      60.5                                                                                                   
  None                                                                                 100                                                                                                    
  Crepitus of motion                                                                   0.109                    Severe---audible and/or palpable grinding and crunching during joint motion   0
  Mild---slightly audible and/or palpable grinding and crunching during joint motion   59.9                                                                                                   
  None                                                                                 100                                                                                                    
  Strength                                                                             0.13                     Trace or no muscle contraction                                                0
  Able to partially complete range of motion against gravity                           36.2                                                                                                   
  Holds test position with minimal resistance                                          60.5                                                                                                   
  Holds test position against gravity with moderate resistance                         79.3                                                                                                   
  Holds test position against gravity with maximum resistance                          100                                                                                                    
  Joint pain                                                                           0.11                     Pain through active range                                                     0
  No pain through active range; pain only on gentle overpressure or palpation          68.7                                                                                                   
  No pain through active range of motion                                               100                                                                                                    
  Global gait (walking, stairs, running, hopping on 1 leg)                             0.138                    No skills are within normal limits                                            0
  3 skills are not within normal limits                                                26.6                                                                                                   
  2 skills are not within normal limits                                                50.6                                                                                                   
  1 skill is not within normal limits                                                  73.3                                                                                                   
  All skills are within normal limits                                                  100                                                                                                    
  Flexion loss (normal--contralateral side)                                            0.115                    Loss of \>20°                                                                 0
  Loss of 11°‐20°                                                                      35.2                                                                                                   
  Loss of 5°‐10°                                                                       71.4                                                                                                   
  Loss of \<5°                                                                         100                                                                                                    
  Extension loss (normal--contralateral side)                                          0.139                    Loss of \>20°                                                                 0
  Loss of 11°‐20°                                                                      38.3                                                                                                   
  Loss of 5°‐10°                                                                       72                                                                                                     
  Loss of \<5°                                                                         100                                                                                                    
  Total                                                                                **1.00**                                                                                                

Item weights indicate how important each item is relative to other items when identifying a healthy joint (N = 41). Attributes for each item level are ranked highest (eg, healthiest) to lowest.
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Figure [2](#rth212212-fig-0002){ref-type="fig"} illustrates the comparison of the original HJHS to the newly developed weighted HJHS. Results from the independent samples *t*‐test indicated that the weighted HJHS, *t*(98) = 7.748; *P* = 8.723e ‐12 had a significantly larger *T* value and a smaller *P* value than the original HJHS, *t*(98) = 3.333; *P* = 0.001 (relative efficiency = 5.4). The weighted HJHS has superior descriptive qualities, which may allow for smaller sample sizes in future studies. This updated system may not only result in a more efficient research tool but may also improve its use clinically.

![This figure illustrates the difference between (A) original HJHS total scores and (B) weighted HJHS total scores](RTH2-3-405-g002){#rth212212-fig-0002}

The method of conjoint analysis using 1000Minds software was successfully implemented in rheumatology to determine preferences for outcome domains in gout[14](#rth212212-bib-0014){ref-type="ref"} and remission and response criteria development.[15](#rth212212-bib-0015){ref-type="ref"} Additionally, it has been used in preferences toward treatment,[16](#rth212212-bib-0016){ref-type="ref"}, [17](#rth212212-bib-0017){ref-type="ref"} and inhibitor care in hemophilia patients.[18](#rth212212-bib-0018){ref-type="ref"} In all examples, the weights were determined by the preferences of the health care professionals or patients/parents, supporting its applicability to this area.

Our sample was a random, representative group of hemophilia musculoskeletal experts, predominantly physiotherapists. We believe the groups we selected have the most valuable perspective given their daily use and application of musculoskeletal examination for people with hemophilia. However, perspectives of other members of the health care team and people with hemophilia will be important for future work. We recognize the importance of including patient preferences and plan to implement this information in a subsequent step toward its future development.

Due to the nature of conjoint analyses, some limitations were identified. Responder fatigue played a strong role in limiting the completion rate. Although the survey was adaptive, reducing the number of explicit comparisons made, the high number of possible pairwise comparisons led to an average of 73 decisions per completed survey. Our completion rate was adequate, but future work should consider methods to reduce respondent burden.

This activity is a preliminary step toward the development of an updated scoring system for the HJHS. As demonstrated by our analysis, a weighted HJHS scoring system should increase its value and utility. Moving forward, optimization of the HJHS should include the integration of patient and clinician preferences, leading to improved clinical assessment and management of joint health, while providing a more robust tool for research.
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